StockDrifts LogoStockDrifts

Osteonics 226400

Company
오스테오닉Osteonics
Insiders
4
Buys
6
Total Value
₩528M ($367K)
Avg Return
-1.03%
Last Filing
2026-03-06

Osteonics (226400) has 6 disclosed insider purchases and 4 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩528M ($367K) in reported transaction value. The earliest filing StockDrifts holds for Osteonics is dated 2023-08-17; the most recent is 2026-03-06. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -1.03%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-03-06SELLMarket Sell
오동선
Oh Dong-seon
moving-4.1K---
2026-01-09BUYMarket Buy
이동원
Lee Dong-won
CEO4.0K₩6,460+2.5%₩26M ($18K)
2026-01-08BUYMarket Buy
이동원
Lee Dong-won
CEO13.9K₩6,230+6.3%₩87M ($60K)
2026-01-07BUYMarket Buy
이동원
Lee Dong-won
CEO15.9K₩6,230+6.3%₩99M ($69K)
2026-01-06BUYMarket Buy
이동원
Lee Dong-won
CEO21.0K₩6,210+6.6%₩130M ($91K)
2026-01-05BUYMarket Buy
이동원
Lee Dong-won
CEO11.1K₩6,510+1.7%₩72M ($50K)
2025-11-25BUYMarket Buy
윤철수
Cheolsu Yoon
Managing Director14.0K₩6,010+10.2%₩84M ($58K)
2025-03-13BUY신규보고
오동선
Oh Dong-seon
Managing Director4.1K₩7,200-8.1%₩29M ($20K)
2025-02-03BUY신규보고
윤철수
Cheolsu Yoon
Managing Director36.0K₩8,110-18.4%₩292M ($203K)
2024-12-31SELL임원퇴임
정의식
definition
Managing Director-20.0K₩6,630+0.1%₩133M ($92K)
2024-12-31SELL임원퇴임
정의식
definition
Managing Director-18.0K₩6,630+0.1%₩119M ($83K)
2024-03-08SELL시간외매매
이동원
Lee Dong-won
CEO-600.0K₩5,320-24.4%₩3.2B ($2.2M)
2024-01-04SELLMarket Sell
서상호
Seo Sang-ho
moving-1.0K₩5,120-29.3%₩5M ($4K)
2023-08-31SELLMarket Sell
서상호
Seo Sang-ho
moving-1.0K₩6,280-5.4%₩6M ($4K)
2023-08-17SELLMarket Sell
서상호
Seo Sang-ho
moving-3.0K₩6,130-8.0%₩18M ($13K)

Frequently asked questions

Who has been buying Osteonics stock?
4 distinct insiders have filed 6 disclosed insider purchases in Osteonics (226400), most recently on 2026-03-06. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Osteonics have?
Osteonics has 6 buy-side and 4 sell-side disclosures on record, covering ₩528M ($367K) in total reported value, spanning 2023-08-17 to 2026-03-06.
Where does StockDrifts get Osteonics insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Osteonics. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.